Efficacy and safety of insulin degludec in Japanese type 2 diabetes
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000011550
- Lead Sponsor
- Center for Diabetes, Metabolism and Endocrinology, Kansai Electric Power Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1)severe ketosis, diabetic coma (2)history of severe hypoglycemia (3)severe renal dysfunction (eGFR <30) and hepatic dysfunction (4)pancreatic deasease, endocrine deasease, taking diabetogenic medication (5)pregnancy (6)unable to self-injection (7)allergy for degludec or glargine (8)judged as ineligible by clinical investigators for some other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method glucose variability by Continuous Glucose Monitoring System
- Secondary Outcome Measures
Name Time Method Frequency of hypoglycemia, Blood glucose plofile measured by SMBG, HbA1c, 1,5-AG, insulin dose